AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)
HRSA-20-066 | HIV/AIDS Bureau
Application Accepted: 09/04/2019 to 11/04/2019
Projected Award Date: 04/01/2020
Estimated Award Amount: N/A
Estimated Number of Awards:N/A
This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF). The Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP) administers this program.
ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to prevent, reduce, or eliminate ADAP waiting lists, including through cost-containment measures (for example, the provision of health insurance assistance). HRSA will base ADAP ERF awards upon applicants’ ability to successfully demonstrate need for additional funding. An external objective review committee (ORC) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists.
HRSA first funded the ERF initiative in August 2010, when numerous states/territories were experiencing ADAP waiting lists. At the time of this NOFO publication, there are no ADAP waiting lists. States/territories that established a waiting list since the publication of this NOFO must report the waiting list to HRSA immediately and use funding awarded under this NOFO to remove clients from the waiting list. HRSA continues to provide funding under this initiative to states/territories that had previously imposed waiting lists to prevent a new waiting list. New this funding year, states/territories may use ERF funds to address current or projected increases in treatment needs aligned with ending the HIV epidemic or other unanticipated increases in the number of the clients in the program who are newly diagnosed or re-engaged in care.1
Applicants are encouraged to consider how their proposed activities with the ADAP ERF funding support HRSA’s emphasis on innovation, collaboration, impact, and effectiveness.
Eligible applicants are limited to RWHAP Part B states/territories that reported to HRSA a current ADAP waiting list, that have used the ADAP ERF to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2019, or that need additional funding for a projected increase in treatment needs aligned with ending the HIV epidemic or other unanticipated increases in the number of the clients in the program who are newly diagnosed or re-engaged in care.
All 50 States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, the Commonwealth of the Northern Mariana Islands, the Republic of Palau, the Federated States of Micronesia, and the Republic of the Marshall Islands are eligible to apply for funding if they meet the above requirements.
States/territories that did not report to HRSA a new ADAP waiting list or use the ADAP ERF to prevent, reduce, or eliminate an ADAP waiting list between January 2011 and July 2018, or that do not have a projected increase in treatment needs aligned with ending the HIV epidemic or other unanticipated increases in the number of the clients in